About CCCC Dividend Returns
C4 Therapeutics, Inc. (CCCC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of CCCC over the past year?
C4 Therapeutics, Inc. (CCCC) delivered a return of -0.37% over the past year. Since CCCC does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in CCCC be worth today?
A $10,000 investment in C4 Therapeutics, Inc. one year ago would be worth $9,963 today, representing a loss of $37.
Q3Does CCCC pay dividends?
C4 Therapeutics, Inc. (CCCC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CCCC, the total return equals the price-only return.
Q4Did CCCC beat the S&P 500?
No, C4 Therapeutics, Inc. (CCCC) underperformed the S&P 500 by 15.82 percentage points over the past year. CCCC delivered a total return of -0.37%, compared to the S&P 500's 15.45%. This means a passive S&P 500 index fund outperformed CCCC by 15.82pp during this period.
Q5What is CCCC's worst drawdown?
C4 Therapeutics, Inc. (CCCC) experienced a maximum drawdown of -59.41% over the past year, declining from its peak on 2025-02-28 to its trough on 2025-04-16. The stock recovered to its prior peak by 2025-08-18. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is CCCC's long-term total return over 10, 20, or 30 years?
C4 Therapeutics, Inc. (CCCC) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -89.4% (-20.1% CAGR) — $10,000 would have grown to $1,059. Over 20 years: -89.4% total return (-10.6% CAGR) — $10,000 → $1,059. Over 30 years: -89.4% total return (-7.2% CAGR) — $10,000 → $1,059. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was CCCC's best and worst year?
C4 Therapeutics, Inc.'s best calendar year was 2020 with a total return of 30.0%. Its worst year was 2022 with a total return of -82.2%. This range shows the volatility investors should expect — the difference between the best and worst year is 112.2 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).